Asbestos in Cosmetics: Talc Risks

Talc and asbestos are both silicate minerals that form in the same geological deposits. When talc is mined from deposits near asbestos, cross-contamination can occur. Complete separation is technically challenging, and no federal law requires cosmetics manufacturers to test for asbestos.

Products containing talc pose the highest risk: baby powder, face powder, foundation, eyeshadow, and blush. Loose powders release more airborne particles than pressed formulations. Major recalls have affected products from J&J, Claire’s, Justice, and others.

Not required. The FDA proposed mandatory testing under the 2022 MoCRA law but withdrew the rule in 2025. Testing remains voluntary and inconsistent. Some brands test extensively; others don’t test at all.

Most users won’t develop disease, but you should document your usage history and mention it to your doctor. Choose talc-free products going forward. If you develop respiratory symptoms or abdominal changes, discuss them with your healthcare provider.

Laura Geller makeup products are formulated without talc , so talc safety is not a concern with this brand. However, research indicates that talc in cosmetics may create inflammation or an environment conducive to cancer development, even if it does not directly cause cancer. Since Laura Geller has removed talc from its formulations, people concerned about talc exposure can use this brand without that particular risk factor, though the brand does contain other ingredients that some toxicologists consider potentially problematic, including octinoxate, phenoxyethanol, and synthetic colorants.

Research consistently reports that there is no completely safe level of asbestos exposure, because any inhaled fibers can lodge in the body and remain there for decades. However, the overall risk from a small, brief exposure is generally low, especially compared with long-term or occupational exposure that lasts months or years. Studies and public health agencies describe a dose-response relationship, meaning that lifetime risk rises with the total amount and duration of exposure. Occasional or one-time exposure has been associated with mesothelioma in rare cases, but most people with minimal exposure do not develop asbestos-related disease.

Talc that contains asbestos is widely recognized as carcinogenic, particularly for cancers in and around the lungs when inhaled. For asbestos free talc used in consumer products, major studies and reviews show mixed findings: some large cohorts find no significant link with ovarian cancer, while pooled case control data suggest about a 20–30% relative increase in ovarian cancer risk for long term genital use, raising lifetime risk estimates from roughly 1.3% to around 1.7–1.8%. The International Agency for Research on Cancer classifies talc with asbestos as “carcinogenic to humans” and genital use of talc based body powder as “possibly carcinogenic to humans,” reflecting limited but concerning human evidence. Research on links to other cancers, such as uterine or stomach cancer, has not shown consistent or strong associations, and studies of cosmetic grade talc in makeup or for medical pleurodesis have not demonstrated clear cancer signals. Overall, current evidence suggests a definite cancer risk from asbestos contaminated talc and a small, still debated possible risk from long term genital use of asbestos free talc.

No, FDA testing for asbestos in talc-containing makeup has not stopped. Agency documents show that since 2018 the FDA has continued commissioning outside laboratories to test talc-based cosmetics using methods such as Polarized Light Microscopy and Transmission Electron Microscopy, and recent sampling (2021 to 2023) did not detect asbestos in the 50 products tested each year. What changed is regulatory, not the surveillance itself. A proposed rule that would have made standardized asbestos testing mandatory for cosmetic manufacturers was introduced in late 2024, then withdrawn in 2025 after public comments. Under the Modernization of Cosmetics Regulation Act of 2022, FDA is still legally required to issue a final rule on standardized testing, but the timeline remains uncertain and current industry testing remains largely voluntary.